Becton Dickinson Investors Seek Final OK Of $9M Deal
By Sydney Price · July 22, 2025, 11:55 PM EDT
Investors in medical tech manufacturer Becton Dickinson are seeking final approval of their $9 million deal that will end derivative claims the company was damaged by its attempts to hide regulatory...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login